Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: The EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy)

Gut

Volumn 64, Issue 9, 2015, Pages 1389-1396

  Zorzi, Manuel ^a   Senore, Carlo ^b   Da Re, Filippo ^a   Barca, Alessandra ^a   Bonelli, Luigina Ada ^c   Cannizzaro, Renato ^d   Fasoli, Renato ^e   Furia, Lucia Di ^a   Giulio, Emilio Di ^f   Mantellini, Paola ^a   Naldoni, Carlo ^a   Sassatelli, Romano ^g   Rex, Douglas ^h   Hassan, Cesare ⁱ   Zappa, Marco ^a  

^a Registro Tumori del Veneto ^*  (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^e SANTA CHIARA HOSPITAL   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g S MARIA NUOVA HOSPITAL   (Italy)

^h INDIANA UNIVERSITY   (United States)

ⁱ NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CASE STUDY; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; ENDOSCOPIST; FECAL IMMUNOCHEMICAL TEST; FEMALE; GASTROENTEROLOGIST; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; IMMUNOCHEMISTRY; ITALY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PRIORITY JOURNAL; QUALITY CONTROL; SEDATION; ADENOMA; AGE; CLINICAL TRIAL; COLORECTAL NEOPLASMS; CONFIDENCE INTERVAL; EARLY DIAGNOSIS; EVALUATION STUDY; HEALTH CARE QUALITY; IMMUNOHISTOCHEMISTRY; INCIDENCE; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ORGANIZATION AND MANAGEMENT; PROCEDURES; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; TASK PERFORMANCE; TOTAL QUALITY MANAGEMENT;

ADENOMA; AGE FACTORS; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; ITALY; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; OCCULT BLOOD; QUALITY ASSURANCE, HEALTH CARE; RISK ASSESSMENT; SEX FACTORS; TASK PERFORMANCE AND ANALYSIS; TOTAL QUALITY MANAGEMENT;

EID: 84941277345     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-307954     Document Type: Article

References (46)

1. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544-73.
2. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-92.
3. Towler BP, Irwig L, Glasziou P, et al. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev 2000:CD001216.
4. Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008;103:1541-9.
5. Hol L, Wilschut JA, Van Ballegooijen M, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009;100:1103-10.
6. Hassan C, Rossi PG, Camilloni L, et al. Meta-analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test. Aliment Pharmacol Ther 2012;36:929-40.
7. Zorzi M, Fedato C, Grazzini G, et al. [Screening for colorectal cancer in Italy, 2010 survey]. Epidemiol Prev 2012;36:55-77.
8. Stegeman I, De Wijkerslooth TR, Mallant-Hent RC, et al. Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round. BMC Gastroenterol 2012;12:73.
9. Singh H, Nugent Z, Demers AA, et al. Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol 2010;105:2588-96.
10. Singh H, Nugent Z, Demers AA, et al. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 2010;139:1128-37.
11. Singh H, Turner D, Xue L, et al. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 2006;295:2366-73.
12. Baxter NN, Sutradhar R, Forbes SS, et al. Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology 2011;140:65-72.
13. Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010;362:1795-803.
14. Rogal SS, Pinsky PF, Schoen RE. Relationship between detection of adenomas by flexible sigmoidoscopy and interval distal colorectal cancer. Clin Gastroenterol Hepatol 2013;11:73-8.
15. Brenner H, Chang-Claude J, Seiler CM, et al. Interval cancers after negative colonoscopy: population-based case-control study. Gut 2012;61:1576-82.
16. Segnan N, Senore C, Andreoni B, et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 2007;132:2304-12.
17. Lee TJ, Rutter MD, Blanks RG, et al. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme. Gut 2012;61:1050-7.
18. Bryk AS, Raudenbush SW. Hierarchical Linear Models. Newbury Park, California: Sage 1992.
19. Goldstein H, Rasbash J, Yang M, et al. A multilevel analysis of school examination results. Oxford Review of Education 1993;19:425-33.
20. I numeri del cancro in Italia 2011. Brescia, Italy: Intermedia Editore 2011:37-42. www.registri-tumori.it/cms/node/2172 (accessed 15 May 2014)
21. Denters MJ, Deutekom M, Bossuyt PM, et al. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer. Gastroenterology 2012;142:497-504.
22. Crotta S, Segnan N, Paganin S, et al. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. Clin Gastroenterol Hepatol 2012;10:633-8.
23. Shah HA, Paszat LF, Saskin R, et al. Factors associated with incomplete colonoscopy: a population-based study. Gastroenterology 2007;132:2297-303.
24. Chokshi RV, Hovis CE, Hollander T, et al. Prevalence of missed adenomas in patients with inadequate bowel preparation on screening colonoscopy. Gastrointest Endosc 2012;75:1197-203.
25. Adler A, Wegscheider K, Lieberman D, et al. Factors determining the quality of screening colonoscopy: a prospective study on adenoma detection rates, from 12, 134 examinations (Berlin colonoscopy project 3, BECOP-3). Gut 2013;62:236-41.
26. Gurudu SR, Ramirez FC, Harrison ME, et al. Increased adenoma detection rate with system-wide implementation of a split-dose preparation for colonoscopy. Gastrointest Endosc 2012;76:p603-8 e1.
27. Jover R, Zapater P, Polania E, et al. Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies. Gastrointest Endosc 2013;77:p381-9 e1.
28. Gavin DR, Valori RM, Anderson JT, et al. The national colonoscopy audit: a nationwide assessment of the quality and safety of colonoscopy in the UK. Gut 2013;62:242-9.
29. Radaelli F, Meucci G, Sgroi G, et al. Technical performance of colonoscopy: the key role of sedation/analgesia and other quality indicators. Am J Gastroenterol 2008;103:1122-30.
30. Ricci E, Hassan C, Petruzziello L, et al. Inter-centre variability of the adenoma detection rate: A prospective, multicentre study. Dig Liver Dis 2013;45:1022-7.
31. Bretagne JF, Hamonic S, Piette C, et al. Variations between endoscopists in rates of detection of colorectal neoplasia and their impact on a regional screening program based on colonoscopy after fecal occult blood testing. Gastrointest Endosc 2010;71:335-41.
32. Rex DK, Bond JH, Winawer S, et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U. S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2002;97:1296-308.
33. Cooper GS, Xu F, Barnholtz Sloan JS, et al. Prevalence and predictors of interval colorectal cancers in medicare beneficiaries. Cancer 2012;118:3044-52.
34. Rex DK, Rahmani EY, Haseman JH, et al. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997;112:17-23.
35. Rabeneck L, Paszat LF, Saskin R. Endoscopist specialty is associated with incident colorectal cancer after a negative colonoscopy. Clin Gastroenterol Hepatol 2010;8:275-9.
36. Hassan C, Rex DK, Zullo A, et al. Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists. Cancer 2012;118:4404-11.
37. Leyden JE, Doherty GA, Hanley A, et al. Quality of colonoscopy performance among gastroenterology and surgical trainees: a need for common training standards for all trainees? Endoscopy 2011;43:935-40.
38. Rex DK. Does the use of sedation, or the level of sedation, affect detection during colonoscopy? Am J Gastroenterol 2012;107:1849-51.
39. Bannert C, Reinhart K, Dunkler D, et al. Sedation in screening colonoscopy: impact on quality indicators and complications. The American journal of gastroenterology 2012;107:1837-48.
40. Wang A, Hoda KM, Holub JL, et al. Does level of sedation impact detection of advanced neoplasia? Digest Dis Sci 2010;55:2337-43.
41. Paspatis GA, Tribonias G, Manolaraki MM, et al. Deep sedation compared with moderate sedation in polyp detection during colonoscopy: a randomized controlled trial. Colorectal Dis 2011;13:e137-44.
42. Lee TJ, Rees CJ, Blanks RG, et al. Colonoscopic factors associated with adenoma detection in a national colorectal cancer screening program. Endoscopy 2014;46:203-11.
43. Murray M, Swan AV, Kiryluk S, et al. The Hawthorne effect in the measurement of adolescent smoking. Journal of epidemiology and community health 1988;42:304-6.
44. Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 2014;370:1298-306.
45. Von Karsa L, Patnick J, Segnan N, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 2013;45:51-9.
46. Coe SG, Crook JE, Diehl NN, et al. An endoscopic quality improvement program improves detection of colorectal adenomas. Am J Gastroenterol 2013;108:219-26.